Ceapro Inc. (Ceapro) is a biotechnology company engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The Company�s primary business activities relate to the marketing and development of various health and wellness products and technology relating to plant extracts. Its product pipeline include Oat Products and Botanical Products. Oat Products include CP Oat Avenanthramides, CP Oat Beta Glucan and Oat Oil. The oat-derived compounds avenanthramides and beta glucan constitute its core product base. Its Botanical Products include CP Sweet Blue Lupin. Ceapro operates in one industry segment, which is the active ingredient product technology industry. The majority of the revenue is derived from sales in North America.